Work

Abstract PS2-10-17: Potential of MEK Inhibition to overcome Trastuzumab deruxtecan Resistance in MAPK-Activated Triple-Negative Breast Cancer PDX Models

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-10-17

Authors: A. Gonzalez Gonzalez, Z. Guo, T. D. Lorentzen, J. Luo, L. Zhao, X. Shan, M. Highkin, J. Hoog, S. Davies, L. Ding, S. Li, A. Vindigni, R. Bose, A. Paulovich, C. X. Ma

Institutions: Washington University in St. Louis, Fred Hutch Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130707224

Cites:

Cited by:

Related to: